Dr. Adebiyi is a NextGen Precision Health Investigator and Tenured Medical Pharmacology & Physiology Professor at the University of Missouri – Columbia, Missouri, United States. He holds the Russell D. and Mary B. Shelden Missouri Chair in Anesthesiology. Dr. Adebiyi’s research broadly focuses on renal and vascular pathophysiology in neonates and adults. His team utilizes an integrative approach, including molecular, biochemical, electrophysiology, imaging, isolated tissue, and whole animal methodologies to investigate the function and control of ion channels, regulatory proteins, oxyradicals, and G protein-coupled receptors in vascular and kidney tissues and cells. His lab is equipped to study vascular and kidney pathophysiology using small and large animal disease models, including hypertension, acute kidney injury, chronic kidney disease, diabetic kidney disease, and sickle cell nephropathy. His laboratory is one of the few groups that utilize translational swine models to investigate the basic science of kidney microcirculation and dysfunction within the first week of life. Dr. Adebiyi has secured millions of dollars in funding from the National Institutes of Health and the American Heart Association (AHA). He has also received numerous meritorious awards. Dr. Adebiyi has published dozens of peer-reviewed research papers in prestigious journals and served as a grant reviewer for several national and international agencies, including the NIH, AHA, Czech Science Foundation, Netherlands Organization for Health Research and Development, and Medical Research Council, United Kingdom.